Judy Stein

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 298 citations · Full text

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 153 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +10

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 123 citations · Full text

Vaccination, Open-label Phase 1, Vaccine Target +10

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

Richard L Wu, Azza H. Idris, Nina M. Berkowitz et al. · New England Journal of Medicine · 2022 · 114 citations · Full text

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

Martin R. Gaudinski, Katherine V. Houser, Nicole A. Doria‐Rose et al. · The Lancet HIV · 2019 · 105 citations · Full text

Immunology, Pharmacology, Therapeutic Efficacy +8